Reducing disability in the tiniest patients

149 Medical aims to commercialize the first non-invasive monitor that measures real-time brain hemodynamics and metabolism in preterm newborns, second by second. It will provide early actionable alerts and continuous feedback allowing for early intervention and treatment monitoring. Clinical advisors state: our device will change the standard of care by improving lives, reducing medical errors, and reducing overall healthcare costs.


Contact Us

If you would like to get more information complete the form below, or e-mail us at info (at) .

Please complete the form below

Name *